passionately pursuing a better life for patients with cancer. follow our pursuit

AVEO Oncology Announces Submission of New Drug Application to U.S. FDA for Tivozanib...

read more »

AVEO Oncology and Biodesix to Discontinue CyFi-2 Study of Ficlatuzumab in Relapsed a...

read more »